Tyler Shropshire

Vice President, Global Biopharma Business Development, Head Of Real World Data at Caris Life Sciences

Tyler Shropshire's work experience includes the following roles:

1. Vice President, Global Biopharma Business Development, Head of Real World Data at Caris Life Sciences (2021-present): Responsible for all aspects of the Real World Data (RWD) biopharma business unit.

2. Senior Director Business Development at Tempus Labs, Inc. (2020-2021): Worked in RWD business development, focusing on strategy and the deployment of multi-omic data products across biopharma. Responsible for partnering with top biopharma companies and startup companies for various data products.

3. Director of Strategic Business Development at Ontera (2019-2020): Played a key role in strategic business development.

4. Senior Scientist / Scientific Management at Ontera (2016-2019): Held a senior scientific position involving scientific management.

5. Scientist at Ontera (2014-2016): Started as a Scientist I and later became a Scientist II.

6. Graduate Student Researcher at the University of California Santa Barbara (2008-2014): Conducted research as a graduate student.

7. Research Associate II at Dendreon (2005-2008): Held a research position.

Tyler Shropshire attended the University of Washington from 2001 to 2006, where they obtained a Bachelor of Science (B.S.) in Biochemistry and a Bachelor of Arts (B.A.) in Spanish. From 2008 to 2014, they pursued their Doctor of Philosophy (Ph.D.) in Biochemistry at UC Santa Barbara. Currently, they are enrolled at The University of Iowa Tippie College of Business, pursuing a Master of Business Administration (MBA) degree with a focus on Finance, General. Additionally, in 2003 and 2004, Tyler also studied at Universidad de Cádiz, where they earned a Bachelor of Arts (BA) degree.

Location

Las Vegas, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Caris Life Sciences

5 followers

Caris Life Sciences is a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine through quality and innovation.


Industries

Employees

1,001-5,000

Links